MetLife, Inc.
MET - NYSE - $79.90 ▲ +%1.20
-
Earnings Wed 6 May
Note: this preview was published before the 2026-05-06 earnings report. Results have since been released — verify against the latest filings.

MetLife opens the
books on Wednesday evening.

5 analysts' median target is $97[FMP target], stock is $80, +20.8% upside potential. After Q4 +10.3% EPS beat[FMP earnings], the stock moved -3.4%.

summary below
Quick Take - in 40 seconds
B+
BUY Council 3/6 - Moonshot 47

B+ = MoonshotScore 47[9-pillar formula] + Council 3/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q4 consensus: revenue $19.5B[FMP est], EPS $2.25[FMP est]. 2 consecutive quarters of beat[FMP earnings].

$2.25 EPS Estimate Last year $2.58 - +15% YoY YoY
2 Beat Streak Expectations beaten consecutively for the last 2 quarters

Q4 EPS +10.3% beat[FMP] but the stock -3.4% D+1[FMP D+1]. John McCallion promised $0 CapEx + a sequential decline in Q4 during the Q4 earnings call[John McCallion capex transcript].

Watchlist

6 metrics stand out this quarter.

$742 billion Investor Focus

Mim Aum Growth

mim_aum_growth

At year-end, MIM had $742 billion of assets under management, up from roughly $600 billion a year ago.

"To accelerate growth in asset management, we closed on the acquisition of PineBridge Investments and established a new business segment, MetLife Investment Management. At year-end, MIM had $742 billion of assets under management, up from roughly $600 billion a year ago."

- Michel Khalaf, President and Chief Executive Officer - Q4 FY25 Earnings Call - February 5, 2026
$100 million Investor Focus

Group Benefits Growth

group_benefits_growth

MetLife's best-in-class group benefits business added approximately $100 million of new adjusted premiums, fees, and other revenues in 2025.

"Reinforcing our market leadership, our best-in-class group benefits business added approximately $100 million of new adjusted premiums, fees, and other revenues in 2025, with higher margin voluntary PFOs rising 10% year over year."

- Michel Khalaf, President and Chief Executive Officer - Q4 FY25 Earnings Call - February 5, 2026
18% Investor Focus

Asia Sales Growth

asia_sales_growth

In 2025, Asia saw constant currency sales jump 18%, aided by a strong contribution from Japan, while Latin America saw constant currency sales rise by 12%, with Mexico leading the charge.

"In 2025, Asia saw constant currency sales jump 18%, aided by a strong contribution from Japan, while Latin America saw constant currency sales rise by 12%, with Mexico leading the charge."

- Michel Khalaf, President and Chief Executive Officer - Q4 FY25 Earnings Call - February 5, 2026
$25 billion Investor Focus

Free Cash Flow Generation

free_cash_flow_generation

In 2025, we made a $4.9 billion down payment toward that cumulative target.

"And where it all comes together, free cash flow-we committed to generate $25 billion over the course of five years. In 2025, we made a $4.9 billion down payment toward that cumulative target."

- Michel Khalaf, President and Chief Executive Officer - Q4 FY25 Earnings Call - February 5, 2026
$14 billion Risk Indicator

Pension Risk Transfer

pension_risk_transfer

MetLife originated more than $14 billion of pension risk transfer sales in 2025, MetLife's highest ever annual PRT total.

"We capitalize on our unique retirement platform by seeding a sidecar, Chariot Re, tapping the US retail retirement space via flow reinsurance, and originating more than $14 billion of pension risk transfer sales, MetLife's highest ever annual PRT total."

- Michel Khalaf, President and Chief Executive Officer - Q4 FY25 Earnings Call - February 5, 2026
11.7% Investor Focus

Expense Ratio Improvement

expense_ratio_improvement

In 2025 alone, aided by AI and other emerging technologies, we lowered our direct expense ratio to 11.7%, putting us well ahead of schedule.

"In 2025 alone, aided by AI and other emerging technologies, we lowered our direct expense ratio to 11.7%, putting us well ahead of schedule."

- Michel Khalaf, President and Chief Executive Officer - Q4 FY25 Earnings Call - February 5, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 3 / 6 Bullish

6 investor frameworks. 3 bullish (Ray Dalio, Ken Griffin, Buffett), 0 bearish (none), 3 neutral (Jim Simons, Klarman, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +20.8%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 66
Klarman value - target upside +20.8%
Buffett quality - ROE score 4/5
Munger valuation - target upside +20.8%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
66.3 RSI 66.3 positive momentum, 50d above
MACD
+8.80 price above 50d - support positive
50d MA
$73 stock 8.8% above - short-term support
200d MA
$77 stock 3.2% above - long-term support
Volume (10d)
-10% decrease - low participation
Resistance
$97
Analyst median target - upgrade trigger if broken
Current
$80
Pre-earnings position
Support
$66
Invalidation - close below this is a technical breakdown
Pattern
Range
$66-$97 band - earnings breakout/breakdown trigger

Past Performance

MetLife,'s last 8 quarters: 2 consecutive beats.

MISS
Q1 FY25
$1.96 vs $2.00 est - +0.5%
MISS
Q2 FY25
$2.02 vs $2.15 est - -2.8%
BEAT
Q3 FY25
$2.34 vs $2.31 est - -3.4%
BEAT
Q4 FY25
$2.58 vs $2.34 est - -3.4%

Q4 (February 5, 2026): EPS $2.58 vs $2.34 est[FMP], +10.3% beat. D+1 movement: -3.4%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $2.18 (no guidance)

Q4: EPS $2.58 vs $2.34 beat[FMP], stock -3.4% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q4 earnings call.

CapEx shock

Q4 CapEx $0[FMP cashflow]. Q4 op margin 4.7%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q4 EPS > $2.25 + CapEx discipline
Threshold: EPS > $2.25[FMP est].
Target: Break above median target $97[FMP target]; high target $102[FMP] upper bound.
Scenario B - In-Line
EPS approx $2.25 + CapEx < $0
Threshold: EPS approx $2.25[FMP est], Q4 CapEx < $0[FMP].
Target: Consolidation in the band between current $80[FMP] and median $97[FMP].
Scenario C - Miss
EPS < $2.18 or CapEx >= $0
Threshold: EPS < $2.18[FMP estx0.97].
Target: Current $80 below SMA200 $77[FMP], if rejection continues, $66[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 5 analysts say?

Wall Street Consensus
$97
12-month median target price (+20.8% upside potential)
12
BUY
6
HOLD
0
SELL
Risk Management
$66
Invalidation level - critical support threshold
$73 - 50-day MA (above, +8.8%)
$77 - 200-day MA (above, +3.2%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - MET Q4 FY26
B+

You read it in 5 minutes. When the numbers come out on Wednesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Wednesday evening. The framework is ready on this page: Q4 EPS threshold $2.25[FMP], CapEx threshold "below $0"[John McCallion]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

May 6, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
May 7, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Jun 20, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Aug 6, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the MET earnings preview cover?

This MET (MET) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in MET earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.